Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shaw

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Clinical Chemistry|January 1, 1977
Gamma-Glutamyltransferase: kinetic properties and assay conditions when gamma-glutamyl-4-nitroanilide and its 3-carboxy derivative are used as donor substratesL M Shaw, J W London, D Fetterolf, et al.
Clinical Biochemistry|August 29, 1998
Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimusM Oellerich, V W Armstrong, E Schütz, et al.
Clinical Chemistry|December 1, 1975
A systematic approach to enzyme assay optimization illustrated by aminotransferase assaysJ W London, L M Shaw, D Fetterolf, et al.
Clinical Chemistry|April 1, 1985
Factors affecting the binding of disopyramide to serum proteinsL M Shaw, R Altman, B C Thompson, et al.
Transplantation Proceedings|February 1, 1997
Is the glucuronide metabolite of MPA pharmacologically active?I Nowak, J Wu, K L Brayman, et al.
Leukemia & Lymphoma|June 5, 1998
Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthineM A Wasik, I Nowak, Q Zhang, et al.
Therapeutic Drug Monitoring|December 1, 1993
The use of concentration measurements of parent drug and metabolites during clinical trialsL M Shaw, H S Bonner, L Fields, et al.
The Biochemical Journal|September 1, 1976
Determination of the mechanism and kinetic constants for hog kidney gamma-glutamyltransferaseJ W London, L M Shaw, D Fetterolf, et al.
Clinical Biochemistry|March 10, 2001
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patientsL M Shaw, M Korecka, D DeNofrio, et al.
Transplantation|December 27, 1995
Diurnal variation of cyclosporine clearance in stable renal transplant recipients receiving continuous infusionM Heifets, G F Cooney, L M Shaw, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Clinical Chemistry|January 1, 1977
Gamma-Glutamyltransferase: kinetic properties and assay conditions when gamma-glutamyl-4-nitroanilide and its 3-carboxy derivative are used as donor substratesL M Shaw, J W London, D Fetterolf, et al.
Clinical Biochemistry|August 29, 1998
Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimusM Oellerich, V W Armstrong, E Schütz, et al.
Clinical Chemistry|December 1, 1975
A systematic approach to enzyme assay optimization illustrated by aminotransferase assaysJ W London, L M Shaw, D Fetterolf, et al.
Clinical Chemistry|April 1, 1985
Factors affecting the binding of disopyramide to serum proteinsL M Shaw, R Altman, B C Thompson, et al.
Transplantation Proceedings|February 1, 1997
Is the glucuronide metabolite of MPA pharmacologically active?I Nowak, J Wu, K L Brayman, et al.
Leukemia & Lymphoma|June 5, 1998
Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthineM A Wasik, I Nowak, Q Zhang, et al.
Therapeutic Drug Monitoring|December 1, 1993
The use of concentration measurements of parent drug and metabolites during clinical trialsL M Shaw, H S Bonner, L Fields, et al.
The Biochemical Journal|September 1, 1976
Determination of the mechanism and kinetic constants for hog kidney gamma-glutamyltransferaseJ W London, L M Shaw, D Fetterolf, et al.
Clinical Biochemistry|March 10, 2001
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patientsL M Shaw, M Korecka, D DeNofrio, et al.
Transplantation|December 27, 1995
Diurnal variation of cyclosporine clearance in stable renal transplant recipients receiving continuous infusionM Heifets, G F Cooney, L M Shaw, et al.
Pageof 20